These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35154148)

  • 1. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
    Liu Z; Xu H; Weng S; Ren Y; Han X
    Front Immunol; 2022; 13():828330. PubMed ID: 35154148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
    Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
    Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance.
    Zheng K; Hai Y; Xi Y; Zhang Y; Liu Z; Chen W; Hu X; Zou X; Hao J
    J Transl Med; 2023 Nov; 21(1):789. PubMed ID: 37936202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
    Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
    Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus clustering and development of a risk signature based on trajectory differential genes of cancer-associated fibroblast subpopulations in colorectal cancer.
    Yu K; Wang J; Wang Y; He J; Hu S; Kuai S
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):388. PubMed ID: 39120743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma.
    Liu L; Liu Z; Gao J; Liu X; Weng S; Guo C; Hu B; Wang Z; Zhang J; Shi J; Guo W; Zhang S
    Front Immunol; 2022; 13():964190. PubMed ID: 35967384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer.
    Chen DY; Zhang YY; Nie HH; Wang HZ; Qiu PS; Wang F; Peng YN; Xu F; Zhao Q; Zhang M
    Sci Rep; 2024 Feb; 14(1):4459. PubMed ID: 38396064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
    Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Heterogeneity of Tumor Cells and its Impact on Colon Cancer Metastasis: Insights from Single-Cell and Bulk Transcriptome Analyses.
    Jia Y; Feng G; Chen S; Li W; Jia Z; Wang J; Li H; Hong S; Dai F
    J Cancer; 2024; 15(13):4175-4196. PubMed ID: 38947396
    [No Abstract]   [Full Text] [Related]  

  • 12. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
    Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.
    Yuan Q; Lu X; Guo H; Sun J; Yang M; Liu Q; Tong M
    J Transl Med; 2023 Nov; 21(1):871. PubMed ID: 38037058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.
    Becht E; de Reyniès A; Giraldo NA; Pilati C; Buttard B; Lacroix L; Selves J; Sautès-Fridman C; Laurent-Puig P; Fridman WH
    Clin Cancer Res; 2016 Aug; 22(16):4057-66. PubMed ID: 26994146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients.
    Liu M; Zhou R; Zou W; Yang Z; Li Q; Chen Z; Jiang L; Zhang J
    Stem Cell Res Ther; 2023 Sep; 14(1):238. PubMed ID: 37674202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer.
    Zhang T; Li J; Dai J; Yuan F; Yuan G; Chen H; Zhu D; Mao X; Qin L; Liu N; Yang M
    Cancer Genet; 2023 Aug; 276-277():48-59. PubMed ID: 37487324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies.
    Liu Z; Guo Y; Yang X; Chen C; Fan D; Wu X; Si C; Xu Y; Shao B; Chen Z; Dang Q; Cui W; Han X; Ji Z; Sun Z
    Front Cell Dev Biol; 2021; 9():784199. PubMed ID: 35083217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.
    Xiao Y; Ma D; Zhao S; Suo C; Shi J; Xue MZ; Ruan M; Wang H; Zhao J; Li Q; Wang P; Shi L; Yang WT; Huang W; Hu X; Yu KD; Huang S; Bertucci F; Jiang YZ; Shao ZM;
    Clin Cancer Res; 2019 Aug; 25(16):5002-5014. PubMed ID: 30837276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study.
    Jiang A; Pang Q; Gan X; Wang A; Wu Z; Liu B; Luo P; Qu L; Wang L
    Cancer Innov; 2022 Aug; 1(2):146-167. PubMed ID: 38090653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.